Valsartan Safety Questions, Valsartan Answers
More Here>>Side Effects - FDA Reports 2006-2008
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y ZWelcome! Patientsville.com provides information about Valsartan side effects. Check out Health Surveys and Health Polls. If you have questions about Valsartan, you can post them to our Doctors or Ask Patient Community about Valsartan.
>> Announcements
Check out our Hospital and Home Care Quality Reports.
Help Community - Post Your Side Effect
Ask Our Doctors about Valsartan
Valsartan Safety Reports
Total Valsartan reports: 117.Valsartan FDA safety alerts: No.
Reported deaths: 9 Reported hospitalizations: 79.
Take Valsartan Side Effects Survey or Share Your Valsartan Story.
Reported Valsartan Side Effects: diabetes mellitus, hepatic function abnormal, chest pain, hypercholesterolaemia, asthenia, anaemia macrocytic, gamma-glutamyltransferase increased, diverticulum intestinal, concomitant disease progression, colonic polyp, arteriovenous malformation.
More About Valsartan.
< Previous Showing 101-117 of 117
Valsartan Side Effects Report #5157079-1Physician from GERMANY reported VALSARTAN problem on Nov 15, 2006. Male patient was diagnosed with hypertension, tachyarrhythmia, transient ischaemic attack and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: tachycardia. VALSARTAN dosage: unknown. During the same period patient was treated with METOPROLOL, DIGITOXIN, CLOPIDOGREL. Patient recovered.
Valsartan Side Effects Report #5162527-7
VALSARTAN problem was reported by a Physician from BRAZIL on June 30, 2004. Male patient, 74 years of age, weighting 151.0 lb, was diagnosed with diabetes mellitus non-insulin-dependent, hypertension and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: anaemia, angiodysplasia, arteriovenous malformation, asthenia, chest pain, colonic polyp, concomitant disease progression, diverticulum intestinal, enterectomy. VALSARTAN dosage: 160 MG. During the same period patient was treated with NATEGLINIDE, AMLODIPINE. Patient was hospitalized. Patient recovered.
Valsartan Side Effects Report #5165317-4
Consumer or non-health professional from JAPAN reported VALSARTAN problem on Nov 15, 2006. Female patient, 39 years of age, was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: caesarean section, oligohydramnios. VALSARTAN dosage: 80 MG/DAY. Patient recovered.
Valsartan Side Effects Report #5167818-1
VALSARTAN problem was reported by a Physician from BRAZIL on June 30, 2004. Male patient, 74 years of age, weighting 151.0 lb, was diagnosed with diabetes mellitus non-insulin-dependent, hypertension and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: anaemia, angiodysplasia, arteriovenous malformation, asthenia, blood pressure increased, chest pain, colonic polyp, concomitant disease progression, diverticulum intestinal. VALSARTAN dosage: 160 MG. During the same period patient was treated with NATEGLINIDE, AMLODIPINE. Patient was hospitalized. Patient recovered.
Valsartan Side Effects Report #5175456-X
Physician from BRAZIL reported VALSARTAN problem on June 30, 2004. Male patient, 74 years of age, weighting 151.0 lb, was diagnosed with diabetes mellitus non-insulin-dependent, hypertension and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: anaemia, angiodysplasia, arteriovenous malformation, asthenia, chest pain, colonic polyp, concomitant disease progression, diverticulum intestinal, enterectomy. VALSARTAN dosage: 160 MG. During the same period patient was treated with NATEGLINIDE, AMLODIPINE. Patient was hospitalized. Patient recovered.
Valsartan Side Effects Report #5181088-X
VALSARTAN problem was reported by a Consumer or non-health professional from JAPAN on Nov 15, 2006. Female patient, 39 years of age, was diagnosed with hypertension and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: caesarean section, oligohydramnios. VALSARTAN dosage: 80 MG/DAY. Patient recovered.
Valsartan Side Effects Report #5198449-5
Pharmacist from UNITED STATES reported VALSARTAN problem on Dec 28, 2006. Female patient, 59 years of age, weighting 132.3 lb, was diagnosed with hypertension, hiatus hernia and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: chromaturia, decreased appetite, jaundice, nausea, ocular icterus, weight decreased. VALSARTAN dosage: unknown. During the same period patient was treated with ACIPHEX, HYDROCHLOROTHIAZIDE, DIGOXIN, ALLEGRA, VIT C, FOSAMAX, ALEVE. Patient was hospitalized. Patient recovered.
Valsartan Side Effects Report #5380523-1
VALSARTAN problem was reported by a Physician from BRAZIL on July 03, 2007. Male patient, 74 years of age, weighting 151.0 lb, was diagnosed with type 2 diabetes mellitus, hypertension and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: anaemia, angiodysplasia, arteriovenous malformation, asthenia, chest pain, colonic polyp, concomitant disease progression, diverticulum intestinal, enterectomy. VALSARTAN dosage: 160 MG. During the same period patient was treated with NATEGLINIDE, AMLODIPINE. Patient was hospitalized. Patient recovered.
Valsartan Side Effects Report #5381498-1
Physician from JAPAN reported VALSARTAN problem on June 29, 2007. Male patient, 63 years of age, weighting 123.5 lb, was diagnosed with hypertension and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: choroidal detachment, constipation, csf cell count abnormal, csf protein increased, diabetes mellitus, gamma-glutamyltransferase increased, hepatic function abnormal, hypercholesterolaemia, insomnia. VALSARTAN dosage: 40 MG/6.25 MG. During the same period patient was treated with PREDNISOLONE. Patient was hospitalized. Patient recovered.
Valsartan Side Effects Report #5389366-6
VALSARTAN problem was reported by a Physician from BRAZIL on July 13, 2007. Male patient, 74 years of age, weighting 151.0 lb, was diagnosed with cardiovascular disorder, type 2 diabetes mellitus, hypertension and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: anaemia, angiodysplasia, arteriovenous malformation, asthenia, chest pain, colonic polyp, concomitant disease progression, diverticulum intestinal, enterectomy. VALSARTAN dosage: unknown. During the same period patient was treated with NATEGLINIDE, AMLODIPINE. Patient was hospitalized. Patient recovered.
Valsartan Side Effects Report #5390032-1
Physician from BRAZIL reported VALSARTAN problem on July 11, 2007. Male patient, 74 years of age, weighting 151.0 lb, was diagnosed with cardiovascular disorder, type 2 diabetes mellitus, hypertension and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: anaemia, angiodysplasia, arteriovenous malformation, asthenia, chest pain, colonic polyp, concomitant disease progression, diverticulum intestinal, enterectomy. VALSARTAN dosage: unknown. During the same period patient was treated with NATEGLINIDE, AMLODIPINE. Patient was hospitalized. Patient recovered.
Valsartan Side Effects Report #5393713-9
VALSARTAN problem was reported by a Pharmacist from UNITED STATES on July 19, 2007. Male patient, 56 years of age, was diagnosed with hypertension and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: hyperkalaemia. VALSARTAN dosage: 160MG EVERY DAY PO. Patient was hospitalized. Patient recovered.
Valsartan Side Effects Report #5397425-7
Pharmacist from UNITED STATES reported VALSARTAN problem on July 23, 2007. Female patient, 83 years of age, was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: angioedema. VALSARTAN dosage: unknown. Patient recovered.
Valsartan Side Effects Report #5404038-7
VALSARTAN problem was reported by a Consumer or non-health professional from FRANCE on July 26, 2007. Male patient, 41 years of age, was diagnosed with hypertension, overweight, diabetes mellitus, dyslipidaemia and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: back pain, blood calcium increased, blood creatinine increased, blood phosphorus decreased, leukocytosis, pyrexia, red blood cell sedimentation rate increased, renal failure acute. VALSARTAN dosage: unknown. During the same period patient was treated with ACOMPLIA, ESOMEPRAZOLE MAGNESIUM, AVANDAMET, DIAMICRON, LIPANTHYL. Patient was hospitalized. Patient recovered.
Valsartan Side Effects Report #5410872-X
Physician from FRANCE reported VALSARTAN problem on Aug 07, 2007. Female patient, 43 years of age, was diagnosed with hypertension and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: abortion induced. VALSARTAN dosage: unknown. Patient recovered.
Valsartan Side Effects Report #5419129-4
VALSARTAN problem was reported by a Physician from JAPAN on Aug 07, 2007. Male patient, 63 years of age, weighting 123.5 lb, was diagnosed with hypertension and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: choroidal detachment, constipation, csf cell count abnormal, csf protein increased, diabetes mellitus, gamma-glutamyltransferase increased, hepatic function abnormal, hypercholesterolaemia, insomnia. VALSARTAN dosage: 40 MG/6.25 MG. During the same period patient was treated with PREDNISOLONE. Patient was hospitalized. Patient recovered.
Valsartan Side Effects Report #5441387-0
Consumer or non-health professional from FRANCE reported VALSARTAN problem on Aug 28, 2007. Male patient, 71 years of age, was diagnosed with hypertension, insomnia, asthma and was treated with VALSARTAN. After drug was administered, patient experienced the following problems/side effects: antinuclear antibody positive, antiphospholipid antibodies positive, coagulation factor viii level decreased, purpura. VALSARTAN dosage: unknown. During the same period patient was treated with RILMENIDINE, NOCTRAN, SERETIDE. Patient was hospitalized. Patient recovered.
< Previous Showing 101-117 of 117